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osting by EAbstract The role of amino acids in diabetes mellitus and its metabolic traits have been suggested
previously; however, studied to a very limited scale in the Saudi patient population. Patients diag-
nosed with diabetes mellitus were included in the current clinical study. Sample was representative
and in accordance with the national population distribution. Blood samples were drawn and
assayed for glucose, total cholesterol, triglyceride, high density lipoprotein and low density lipopro-
tein. General biochemical markers, such as alkaline phosphatase (ALP), creatinine kinase (CK),
aspartate transaminase (AST), alanine transaminase (ALT) and blood urea nitrogen (BUN) were
assessed. Serum amino acids of different categories (essential, semi-essential and metabolic indica-
tor amino acids) were assessed. Correlation co-efﬁcient between each amino acid and serum glucose
level was calculated. The current study showed positive correlation between amino acid level and
glucose serum concentration in male while it showed negative correlation in female Saudi diabetic
patients. Male patients had signiﬁcantly higher methionine concentration parallel to their glycemic
status. Metabolic indicator amino acids signiﬁcantly changed in concordance with the glycemic sta-
tus of female patients more than in male patients. In conclusion, serum amino acid is positively cor-
related with glycemic status in Saudi male diabetic patients while negatively correlated in female
patients. Yet, further study would be recommended to utilize serum amino acid proﬁle as surrogate
parameter for the metabolic complications of diabetes mellitus.
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lsevierIntroduction
Diabetes mellitus (DM) is a very common metabolic disease
with expected worldwide burden of 300 million population in
the year 2020. Kingdom of Saudi Arabia is classiﬁed level-4
DM disease burden with 717,000 patients in the year 2009
[1]. There have been changes over the last 20 years in the geo-
graphical distribution of the incidence of diabetes with signif-
icant decline in the industrialized countries and rise in the
developing countries [2]. Kingdom of Saudi Arabia, a Middle
306 F.A. Al-AbbasiEastern country, experienced signiﬁcant economical improve-
ment over the last 20 years. This has resulted in adopting the
‘‘Western’’ life style with respect to nutritional habits and
physical exercise. Such changes might be coupled with
improvement in health services; while on the other hand it
could be associated with decline in the healthy eating habits
and increase in the consumption of junk food [3].
DM is an insulin/glucose metabolic-endocrinal disease pri-
marily characterized by elevated blood glucose and inability
of glucose utilization in the peripheral tissues such as adipose
and muscle tissues [4]. DM with both its major subtypes, insu-
lin dependent diabetes mellitus and insulin independent diabe-
tes mellitus, is accompanied by several vascular, neurological,
immunological, and biochemical pathological changes [5]. Esti-
mating early signs of these target organs pathological effect
using non-invasive techniques represents an important issue
for clinicians in order to avoid late organ debilitations. Serum
glucose and c-peptide encountered the major classic parame-
ters to assess the glycemic and insulin efﬁciency statuses clini-
cally [6]. In addition, several other biomarkers have been
suggested for detailed or speciﬁc assessment of the diabetic sta-
tus such as glucosenated hemoglobin for long term glycemic
assessment [7].
Amino acids comprise the building blocks of proteins
found in structural tissues of the body. Amino acids are
essential to life in free or polymeric form as peptides. Amino
acids play important roles in activities, such as neurotrans-
mission, pH regulation, cholesterol metabolism, pain control,
detoxiﬁcation, and control of inﬂammatory response [8].
Many amino acids can be synthesized by the body. Others,
the essential amino acids, cannot be endogenously synthe-
sized in adequate amounts, so that they must be obtained
from the diet [9]. The eight essential amino acids in humans
are: isoleucine, leucine, lysine, methionine, phenylalanine,
threonine, tryptophan, and valine [10]. Semi-essential amino
acids are those for which there is some endogenous synthesis,
however, not enough for physiological needs. These include
arginine, histidine, cysteine, and taurine (for infants) [11].
Other amino acids are considered metabolic indicators for
several impairments in metabolism such as, beta-alanine, cit-
rulline, homocysteine, cystathionine, ornithine, and alpha-
aminoadipic acid. These amino acids provide information
on conversion capability in the body or dietary adequacy of
the essential amino acids [12]. Several references donated an
important role of amino acids are a variety of many disor-
ders, nonetheless DM. Some metabolic steps of amino acids
related to vascular complications (methionine and arginine)
exhibit a defective response to insulin in type-2 DM with
nephropathy. However, gross alterations in the response of
whole-body protein turnover are not evident in type-2 DM,
speciﬁc investigations reveal subtle abnormalities in metabolic
steps of selected amino acids [13]. Also it was reported that,
circulating amino acid concentrations do not worsen the al-
ready attenuated glucose disposal in hyperglycemic type 2
diabetic men [14]. Also, speciﬁc amino acid or amino acid
balance could be used as a predictive plasma marker for
Type-2 DM [15].
Herein, in the current study on diabetic Saudi patients, we
are assessing the correlation between the glycemic status of
Saudi DM patients and their serum amino acid proﬁle. This
study might provide new insights into further metabolic inter-
ference of DM in Saudi population.Patients and methods
Subjects
A total of 63 adult DM patients (27 males and 38 females)
entered the study at a time after reading and accepting the insti-
tutional consensus. All participants were clinically diagnosed
type-I DM according to the standard procedures within Saudi
health care institutes (inclusion criteria). Any patient with com-
bined sever illness or sever diabetic complications was excluded
from the study (exclusion criteria). The study design was ap-
proved by the clinical ethics committee in Ministry of Health.
Clinical examination
Body mass index (BMI) was calculated as body weight (in kg)
divided by squared height (inmeters). The procedure for themea-
surements of weight, height, waist circumference and hip circum-
ference, systolic and diastolic blood pressures was according to
the standard procedures within Saudi health care institutes.
Collection of blood samples
Venous blood samples (two samples) were withdrawn from
peripheral vein while the patient is sitting. Blood samples were
allowed to clot, centrifuge and the sera were kept frozen at
20 C for biochemical assessment. Another blood sample
was collected in heparinized tube for amino acid analysis.
Serum glucose determination
Serum samples were used for glucose analysis on a glucose
analyzer (Beckman Paragon, Fullerton, CA, USA). The meth-
od depends on the rate of oxygen consumption by the enzyme
glucose oxidase in order to convert glucose into gluconic acid
and hydrogen peroxide. Oxygen rate consumption was deter-
mined by sensitive oxygen electrode. The instrument was cali-
brated prior to glucose determination using quality control
samples provided with the solutions. The mean values
obtained on the controls were within the values quoted by
the manufacturer. The results were expressed by SI units
(mmol/l). The intra and inter assay coefﬁcients of variation
were 1.7% and 2.6%, respectively.
Biochemical assessments
Biochemical assessments were assessed in isolated sera using
speciﬁc kits purchased fromDade Behring,Marburg,Germany.
Aspartate aminotransferase (AST) and alanine aminotrans-
ferase (ALT) were assessed as previously described [18]. Creat-
inine was determined via picric acid chromophore interaction
assay [19].
Creatinine kinase (CK), alkaline phosphatase (ALP) and
blood urea nitrogen (BUN) were determined in sera using
the manufacturer standard operating protocol of the kit.
Serum lipid analysis
Analysis was done using the Cobas Mira S Clinical Analyzer,
Roche Diagnostics. Unimate 7 cholesterol and Unimate 7
triglyceride were used for measuring total cholesterol and tri-
glycerides, respectively.
Table 1 Glycemic, lipid proﬁle and biochemical parameters in normoglycemic and hyperglycemic Saudi diabetic patients.
Normoglycemic group Hyperglycemic group p-Value
Male (n= 13) Female (n= 14) Male (n= 14) Female (n= 22) Male Female
Glucose 108.7 ± 14.7 110.6 ± 22.6 198.3* ± 71.4 228.5* ± 61.6 0.0005 0.00000035
Cholesterol 170 ± 55.5 169.0 ± 39.7 165.3 ± 33.1 164.7 ± 29.3 0.4 0.365
HDL-c 49.3 ± 8.6 60.5 ± 14.7 55.3 ± 11.8 57.5 ± 7.7 0.112 0.256
LDL-c 99.6 ± 55.7 83.3 ± 23.7 81.4 ± 38.3 79.6 ± 23.6 0.252 0.417
TG 137.1 ± 49.6 138.1 ± 48.1 226.2* ± 166.6 111.5 ± 67.2 0.0449 0.1206
ALP 92.5 ± 29.6 97.7 ± 16.5 103.1 ± 30.5 99.1 ± 19.6 0.2235 0.437
CK 0.98 ± 0.4 0.8 ± 0.3 1.07 ± 0.8 0.6 ± 0.2 0.372 0.022
ALT 23.7 ± 12.7 17.7 ± 7.2 22.9 ± 9.6 18.1 ± 8.2 0.441 0.455
AST 16.2 ± 8.2 16.3 ± 3.6 16.0 ± 7.1 16.3 ± 6.3 0.474 0.499
BUN 19.8 ± 16.2 14.2 ± 4.6 16.7 ± 7.3 12.3 ± 4.3 0.2722 0.123
Table 2 Plasma concentration of essential, semi-essential and metabolic indicator amino acids in normoglycemic and hyperglycemic
Saudi diabetic patients.
Normoglycemic group Hyperglycemic group p-Value
Male Female Male Female Male Female
Essential amino acids
THR 3.0 ± 6.7 3.4 ± 4.6 3.5 ± 4.2 1.7 ± 3.1 0.4058 0.0894
VAL 2.1 ± 2.1 3.6 ± 6.1 3.0 ± 3.3 1.5 ± 2.1 0.1974 0.0651
MET 1.3 ± 2.0 1.1 ± 2.0 3.6* ± 4.4 0.9 ± 2.0 0.0467 0.3901
ILE 2.3 ± 3.3 2.6 ± 3.3 3.1 ± 3.8 1.4 ± 2.2 0.2741 0.1054
TYR 2.8 ± 2.4 4.6 ± 8.2 2.7 ± 3.6 1.4 ± 3.5 0.4768 0.0578
PHE 1.5 ± 2.1 3.4 ± 4.6 3.4 ± 5.9 1.2* ± 2.3 0.1322 0.0350
LEU 2.1 ± 2.4 5.0 ± 8.5 2.8 ± 3.2 1.9 ± 3.0 0.2735 0.0610
LYS 3.6 ± 6.9 7.9 ± 10.4 10.2 ± 13.6 5.1 ± 8.6 0.0660 0.1904
Total 18.7 ± 24.4 31.7 ± 39.5 32.4 ± 34.8 15.1 ± 23.5 0.1250 0.0611
Semi-essential amino acids
TAU 2.5 ± 3.7 2.5 ± 3.6 3.0 ± 3.3 2.3 ± 6.7 0.3642 0.4689
CYS2 1.3 ± 1.4 4.2 ± 5.1 2.3 ± 2.8 1.0* ± 2.4 0.1357 0.0081
HIS 0.6 ± 0.8 1.6 ± 2.8 2.0* ± 3.0 0.4* ± 0.8 0.0475 0.0303
ARG 2.8 ± 4.4 6.1 ± 11.3 4.8 ± 6.6 2.8 ± 4.9 0.1867 0.1173
Total 7. 1 ± 9.1 14.4 ± 17.8 12.0 ± 13.8 6.5 ± 11.1 0.1452 0.0562
Metabolic indicator amino acids
AAA 2.3 ± 2.4 3.9 ± 4.9 2.9 ± 4.3 1.2* ± 2.9 0.3205 0.0238
ALA 1.9 ± 2.2 2.4 ± 3.2 2.3 ± 4.2 0.9 ± 2.6 0.3676 0.0753
CIT 2.0 ± 2.5 3.9 ± 5.1 3.4 ± 5.1 1.5* ± 2.6 0.1816 0.0311
HYC2 1.6 ± 2.3 2.0 ± 2.3 2.2 ± 2.9 0.7* ± 1.3 0.2758 0.0242
ORN 3.0 ± 4.7 4.7 ± 6.7 4.1 ± 4.6 1.3* ± 2.6 0.2720 0.0179
Total 10.7 ± 11.4 16.9 ± 17.9 15.0 ± 16.7 5.6* ± 10.5 0.2258 0.0117
Trend of amino acids proﬁle in Saudi diabetic patients 307The assay for total cholesterol was done using the enzymatic
method, which is an enzymatic colorimetric test with cholesterol
esterase and cholesterol oxidase. Triglycerides were also assayed
using an enzymatic colorimetric test with glycerol phosphate oxi-
dase. A high density lipoprotein (HDL) cholesterol precipitating
reagent, magnesium sulfate at a concentration of 0.26 mol/l was
used to remove low density lipoprotein (LDL) cholesterol, total
cholesterol and very low density lipoprotein (VLDL). HDL cho-
lesterolwas, then, determinedbyan enzymatic colorimetricmeth-
od. LDL cholesterol was estimated by using the formula: LDL
cholesterol = total cholesterol  (HDLcholesterol + 0.46 · tri-
glyceride). The intra and inter-assay coefﬁcients of variationwere
2.2% and 2.6%, respectively, for total cholesterol and 2.2% and
2.2% respectively, for triglycerides [20,21].Amino acid analysis
The plasma was separated from heparinized blood samples by
centrifugation at 4 C, and one aliquot was deproteinized with
sulfosalicylic acid (10% w/v) as described, and the supernatant
was stored along with another aliquot of untreated plasma at
20 C [13]. Individual amino acids were determined on the
SSA supernatants by standard procedures using lithium buffer
systems on a Beckman 121M Amino Acid Analyzer (Beckman
Instruments. Inc., Palo Alto, Ca.). No speciﬁc measures were
taken apart from minimizing the period between sampling
and analysis, to assure the stability of glutamine, glutamate
and aspartate. The values reported reﬂect this approach to
sample handling [16]. Tryptophan was analyzed separately
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Fig. 1 Correlation analysis for the association between fasting blood sugar and essential amino acids concentrations in plasma of male
Saudi diabetic patients.
308 F.A. Al-Abbasiand subsequently in trichloracetic acid precipitated plasma and
dialysate by a ﬂuorimetric method [17].
Data are expressed as mean ± SD. Analysis of variance
(One-way ANOVA) with Tukey’s post hoc test was used for
testing the signiﬁcance of parametric data using SPSS for
windows, version 10.0.1. p< 0.05 was taken as the cut off
value for signiﬁcance.
Results
Assessment of glycemic, lipid proﬁle and biochemical parameters
in Saudi diabetic patients
In the current study, to evaluate the correlation between glyce-
mic status and amino acid proﬁle in Saudi diabetic patients;fasting serum glucose level was taken as the primary criterion
of group segregation into hyperglycemic and normoglycemic
patient. Patient demographic criteria were assessed and there
was no signiﬁcant difference in mean body mass index (BMI)
of different groups, whether among male or female subjects.
Serum glucose of 140 mg% was considered as cut-off value
for hyperglycemia according to the institutional guidelines.
Obviously, mean blood glucose was found signiﬁcantly higher
in hyperglycemic male and female groups (198.3 ± 71.4 and
228.5 ± 61.6 mg%, respectively) compared to their corre-
sponding normoglycemic groups (108.7 ± 14.7 and 110.6
± 22.6 mg%, respectively) (Table 1).
In general, there were no signiﬁcant differences in lipid pro-
ﬁle parameters between normoglycemic and hyperglycemic
corresponding groups with the exception of serum TG. Serum
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Fig. 2 Correlation analysis for the association between fasting blood sugar and essential amino acids concentrations in plasma of female
Saudi diabetic patients.
Trend of amino acids proﬁle in Saudi diabetic patients 309TG in male hyperglycemic patients was elevated to about two
folds its concentration in normoglycemic male group at
p< 0.05 (Table 1).
Also, we assessed several muscle (CK), kidney (BUN), and
liver (ALP, AST and ALT) biochemical markers in hyperglyce-
mic and normoglycemic Saudi diabetic patients. No signiﬁcant
change in all assessed biochemical parameters was detected
with the universal level of signiﬁcance (p< 0.05) (Table 1).
Plasma level of amino acids in Saudi diabetic patients
Concentration of several amino acids of different categories
(essential, semi-essential and metabolic indicator amino acids)was assessed in plasma of hyperglycemic and normoglycemic
diabetic Saudi patients (males and females). Among essential
amino acids, MET showed signiﬁcant increase in plasma con-
centration of male hyperglycemic patient (3.6 ± 4.4 lg/ml)
compared to corresponding normoglycemic group (1.3 ±
2.0 lg/ml). PHE showed signiﬁcant decrease in plasma concen-
tration of female hyperglycemic patient (1.2 ± 2.3 lg/ml) com-
pared to corresponding normoglycemic group (3.4 ± 4.6 lg/
ml) at p< 0.05.No signiﬁcant differences in other essential ami-
no acids between hyperglycemic and normoglycemic diabetic
Saudi patients at P< 0.05 (males and females) (Table 2).
With respect to semi-essential amino acids, plasma
concentrations of both CYS2 and HIS were signiﬁcantly
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Fig. 3 Correlation analysis for the association between fasting blood sugar and semi-essential amino acids concentrations in plasma of
male Saudi diabetic patients.
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Fig. 4 Correlation analysis for the association between fasting blood sugar and semi-essential amino acids concentrations in plasma of
female Saudi diabetic patients.
310 F.A. Al-Abbasidecreased in female hyperglycemic Saudi patients (1.0 ± 2.4
and 0.4 ± 0.8 lg/ml, respectively) compared to normoglycemic
group (4.2 ± 5.1 and1.6 ± 2.8 lg/ml, respectively) at p< 0.05.
On the other hand, plasma concentration of HIS was signiﬁ-
cantly increased in male hyperglycemic Saudi patients
(2.0 ± 3.0 lg/ml) compared to corresponding normoglycemic
(0.6 ± 0.8 lg/ml) group at p< 0.05 (Table 2).Interestingly, allmetabolic indicator amino acidswere signif-
icantly decreased in hyperglycemic female patients to about 25–
40% of its level in the corresponding normoglycemic group
(p< 0.05). On the contrary, the plasma levels of all metabolic
indicator amino acids inmale hyperglycemic patients were high-
er than the corresponding normoglycemic group, however it did
not reach the standard level of signiﬁcance (p< 0.05) (Table 2).
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Fig. 5 Correlation analysis for the association between fasting blood sugar and metabolic indicator amino acids concentrations in
plasma of male Saudi diabetic patients.
Trend of amino acids proﬁle in Saudi diabetic patients 311Correlation between glucose and amino acids concentration in
plasma of Saudi diabetic patients
The correlation between plasma level of several amino acids
and the glycemic status of diabetic Saudi patients (males and
females) was assessed using trend analysis and by calculating
the correlation co-efﬁcient (r). Herein, the absolute value of
r> 0.5 was considered as strong correlation; r< 0.25 will
be described as weak correlation and r ranging from 0.25 to
0.5 will be considered as moderate correlation. The sign before
r (positive or negative) indicates direct or inverse correlation,
respectively. In general, there was clear gender difference in
the correlation between plasma concentrations of sugar and
all categories of amino acids in Saudi diabetic patients; the
plasma level of all amino acids directly increased with the su-
gar concentration in male Saudi diabetic patients while inver-
sely decreased with the increase in sugar concentration in
female Saudi diabetic patients.
There was a positive correlation between all essential amino
acids and blood glucose level in male Saudi diabetic patients.
The correlation ofMET inmale diabetic patientswith blood glu-
cose was strong (r= 0.5), while all other essential amino acids
showed weak correlation (r ranging from 0.08 to 0.24) (Fig. 1).
On the other hand, MET showed almost no correlation withblood glucose level in female diabetic patients (r= 0.0014).
All other amino acids were moderately associated with the plas-
ma level of glucose in female diabetic patients (r ranging from
0.33 to 0.37) (Fig. 2).
In male patients, the correlation of all semi-essential amino
acids with serum glucose level was positive but weak with
r ranging from 0.02 to 0.17 (Fig. 3). On the other hand, the cor-
relation of semi-essential amino acids with serum glucose in
female patients showed some diversity (Fig. 4). High moderate
negative correlation (r= 0.45) was observed between serum
CYS2 and blood glucose in female diabetic patients. HIS and
ARG showed moderate negative correlation with serum glu-
cose with r ranging from 0.32 to 0.37 in female diabetic Saudi
patients. Only TAU showed weak correlation (r= 0.17)
with serum glucose in female Saudi diabetic patients.
Similar to semi-essential amino acid, all metabolic indicator
amino acids showed positive weak to moderate correlation
(r ranging from 0.017 to 0.303) with serum glucose in male
Saudi diabetic patients (Fig. 5). In contrast to male Saudi dia-
betic patients, all amino acids – except ALA – showed moderate
to strong correlation co-efﬁcient in female patients (Fig. 6).
HCY2 and ORN showed boarder line strong negative correla-
tion with glucose level in female diabetic patients with r= 0.5,
respectively. AAA and CIT showed moderate negative
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Fig. 6 Correlation analysis for the association between fasting blood sugar and metabolic indicator amino acids concentrations in
plasma of female Saudi diabetic patients.
312 F.A. Al-Abbasicorrelation with glucose level in female patients with r= 0.44
and 0.42, respectively.
Discussion
Diabetes mellitus is major metabolic disease that is associated
with several disorders such as, microvascular disorders, hyper-
cholesterolemia, obesity, and other nutritional disorders. The
role of amino acids in DM and its metabolic traits have been
suggested previously; however, studied to a very limited scale
in some populations such as Saudi patients. In the current
study, we have assessed the relation between several amino
acids of different category and the glycemic status in Saudi dia-
betic patients. Amino acids assessment can reﬂect and explain
several structural, nutritional, physiological, and biochemical
complications of DM; nonetheless in a population with such
high prevalence of the disease [1].
Only serum TG in male hyperglycemic patients was elevated
in correspondence with the glycemic status. That might be
explained by the disturbance in glycolysis associated lipolysis
in DM rather than direct relation with plasma glucose level.
Also, we cannot ignore nutritional implication that mightaffect serum TG in Saudi diabetic patients. The elevated TG
level in male rather than female diabetic patients might be
attributed to hormonal inﬂuence [22]. Triglycerides are affected
during pregnancy and inﬂuenced by sex hormones [23].
The elevated level of MET in male diabetic patient, herein,
might be an early indicator for impaired MET metabolism
and homocystinuria. Strong correlation between MET and gly-
cemic status in male diabetic patients rather than female might
implicate higher susceptibility of male than female Saudi dia-
betic patients for homocystinuria. In addition, this observation
warrants further studies. Microvascular complications of DM
such as, coronary artery disease, myocardial infarction, periph-
eral and cerebral vascular occlusive diseases and stroke have
been related to homocystinuria [24,25]. The negative correla-
tion between essential/semi essential amino acid and glycemic
status would suggest trend for bad nutritional habits among
female rather than in male Saudi patients. In agreement, dietary
balance has been an old problem for diabetic patients over dec-
ades that warrants careful attention [26,27]. On the other hand,
Saudi male diabetic patients would be more prone to diabetic
microvascular complication secondary to early signs of homo-
cystinuria [28].
Trend of amino acids proﬁle in Saudi diabetic patients 313In the current study, TAU did not show any correlation
with the glycemic status in male or female patients of Saudi
population. Accordingly, no compensatory antioxidant pro-
tective machinery would help in the predicted microvascular
complications, nonetheless, in male patient with hyperglycemia
[29]. Interestingly, the negative correlation between ARG and
glucose in female Saudi patients would produce similar vascu-
lar occlusive complication due to nitric oxide synthesis impair-
ment. The extensive role of ARG in cardiovascular function,
wound healing hormone release (especially insulin and gluca-
gon) and neurotransmission exceeds the synthetic capacity of
human body [30].
All metabolic indicator amino acids showed much stronger
correlation in female Saudi diabetic patients than in male
patients. Taking into consideration the metabolic nature of
DM, we can explain such a phenomenon. However, the stron-
ger correlation in female than in male patients would be sug-
gested to be attributed to sex hormone discrepancies [31].Conclusion
We have shown some correlation between the serum level of
several amino acids of different categories and glycemic status
among Saudi type-1 diabetic patients in a gender dependent
manner. This study and further studies would be required to
provide early vision for predicting some metabolic traits in dia-
betic patients in the Saudi population.Acknowledgment
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